Carcinoid syndrome risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (25 intermediate revisions by 7 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Carcinoid syndrome}} | {{Carcinoid syndrome}} | ||
{{CMG}}{{AE}}{{PSD}} | |||
==Overview== | |||
Common [[risk factors]] in the development of [[Carcinoid Syndrome|carcinoid syndrome]] include [[age]] (50 years or older), [[female]] gender, [[Family history (medicine)|family history]] of [[multiple endocrine neoplasia type 1]] and [[neurofibromatosis type 1]], [[atrophic gastritis]], [[pernicious anemia]], and [[Zollinger-Ellison syndrome]]. | |||
==Risk Factors== | |||
Common [[risk factors]] in the development of [[Carcinoid Syndrome|carcinoid syndrome]] include:<ref name="risk">Health history can affect the risk of gastrointestinal carcinoid tumors. National Cancer Institute. http://www.cancer.gov/types/gi-carcinoid-tumors/patient/gi-carcinoid-treatment-pdq</ref> | |||
*Age (50 years or older) | |||
*Gender: [[Female|female]] | |||
*Race:[[African Americans]] | |||
*Family history of [[multiple endocrine neoplasia type 1]] | |||
*Family history of [[neurofibromatosis type 1]] | |||
*[[Genetic Diseases, Inborn|Genetic syndromes]] such as | |||
#[[Tuberous sclerosis complex]] | |||
#[[Von Hippel Lindau syndrome|Von Hippel Lindau disease]] | |||
#[[Familial|Familial small intestinal neuroendocrine tumor]]<ref name="pmid25865046">{{cite journal |vauthors=Sei Y, Zhao X, Forbes J, Szymczak S, Li Q, Trivedi A, Voellinger M, Joy G, Feng J, Whatley M, Jones MS, Harper UL, Marx SJ, Venkatesan AM, Chandrasekharappa SC, Raffeld M, Quezado MM, Louie A, Chen CC, Lim RM, Agarwala R, Schäffer AA, Hughes MS, Bailey-Wilson JE, Wank SA |title=A Hereditary Form of Small Intestinal Carcinoid Associated With a Germline Mutation in Inositol Polyphosphate Multikinase |journal=Gastroenterology |volume=149 |issue=1 |pages=67–78 |date=July 2015 |pmid=25865046 |pmc=4858647 |doi=10.1053/j.gastro.2015.04.008 |url=}}</ref> | |||
*[[Risk factors]] for [[Carcinoid tumors|carcinoid tumours]] of [[stomach]] | |||
#[[Atrophic gastritis]] | |||
#[[Pernicious anemia]] | |||
#[[Zollinger-Ellison syndrome]] | |||
==References== | ==References== | ||
{{ | {{Reflist|2}} | ||
{{WS}} | |||
{{WH}} | {{WH}} | ||
[[Category: | [[Category:Gastroenterology]] | ||
[[Category: | [[Category:Endocrinology]] | ||
[[Category: | [[Category:Pulmonology]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Medicine]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category: | [[Category:Surgery]] | ||
Latest revision as of 14:00, 2 April 2021
|
Carcinoid syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Carcinoid syndrome risk factors On the Web |
|
American Roentgen Ray Society Images of Carcinoid syndrome risk factors |
|
Risk calculators and risk factors for Carcinoid syndrome risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
Common risk factors in the development of carcinoid syndrome include age (50 years or older), female gender, family history of multiple endocrine neoplasia type 1 and neurofibromatosis type 1, atrophic gastritis, pernicious anemia, and Zollinger-Ellison syndrome.
Risk Factors
Common risk factors in the development of carcinoid syndrome include:[1]
- Age (50 years or older)
- Gender: female
- Race:African Americans
- Family history of multiple endocrine neoplasia type 1
- Family history of neurofibromatosis type 1
- Genetic syndromes such as
- Tuberous sclerosis complex
- Von Hippel Lindau disease
- Familial small intestinal neuroendocrine tumor[2]
- Risk factors for carcinoid tumours of stomach
References
- ↑ Health history can affect the risk of gastrointestinal carcinoid tumors. National Cancer Institute. http://www.cancer.gov/types/gi-carcinoid-tumors/patient/gi-carcinoid-treatment-pdq
- ↑ Sei Y, Zhao X, Forbes J, Szymczak S, Li Q, Trivedi A, Voellinger M, Joy G, Feng J, Whatley M, Jones MS, Harper UL, Marx SJ, Venkatesan AM, Chandrasekharappa SC, Raffeld M, Quezado MM, Louie A, Chen CC, Lim RM, Agarwala R, Schäffer AA, Hughes MS, Bailey-Wilson JE, Wank SA (July 2015). "A Hereditary Form of Small Intestinal Carcinoid Associated With a Germline Mutation in Inositol Polyphosphate Multikinase". Gastroenterology. 149 (1): 67–78. doi:10.1053/j.gastro.2015.04.008. PMC 4858647. PMID 25865046.